BUY Sun Pharmaceutical Industries Ltd. — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Intraday)28 Jul 2026, 9:05 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Sun Pharma announced that Organon shareholders have approved the proposed acquisition, moving forward the company's strategic expansion plans.
BSE · Company Update·24 Jul · 4d ago
3 advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·24 Jul · 4d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sun Pharmaceutical Industries
- BUY — Sumeet Bagadia, Choice Broking23 Oct 2026 · Same day · target ₹1,790 · Expired
- BUY — HSBC Securities7 Oct 2026 · ~1 year · target ₹2,100 · Active
- SELL — Rajesh Palviya, Axis Securities5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY — Sumeet Bagadia, Choice Broking29 Sept 2026 · Same day · target ₹1,875 · Expired
- BUY — 360 One Capital29 Sept 2026 · ~1 year · target ₹2,250 · Active
More from Prakash Gaba
- SELL Kalyan Jewellers India23 Oct 2026 · ~2 weeks · target ₹510 · Target hit
- BUY Shilpa Medicare23 Oct 2026 · ~2 weeks · target ₹900 · SL hit
- SELL Ather Energy23 Oct 2026 · Same day · target ₹1,380 · Target hit
- BUY UltraTech Cement23 Oct 2026 · Same day · target ₹11,200 · SL hit
- BUY The Indian Hotels Company22 Oct 2026 · Next day · target ₹800 · SL hit

